Skip to main content
Clinical Trials/NCT06169813
NCT06169813
Active, not recruiting
Phase 1

Evaluating Smoking Cessation and Harm Reduction Approaches Among People Living With HIV/AIDS in South Africa

NYU Langone Health1 site in 1 country106 target enrollmentApril 15, 2025
ConditionsTobacco Smoking

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Tobacco Smoking
Sponsor
NYU Langone Health
Enrollment
106
Locations
1
Primary Endpoint
Follow-Up Rate at 6 Months
Status
Active, not recruiting
Last Updated
6 months ago

Overview

Brief Summary

The purpose of this pilot randomized controlled trial study aims to address the unmet need for feasible and efficacious strategies for reducing combustible cigarette (CC) use among people living with HIV/AIDS (PLWHA) in South Africa, which has the potential to significantly improve the health and long-term survival of PLWHA CC smokers. Using the proposed intervention, based on the Information-Motivation-Behavioral Skills (IMB), and a simultaneous embedded mixed methods approach, the investigators will evaluate a telehealth program targeting CC harm reduction, comparing E-cigarettes (EC) to nicotine replacement therapy (NRT) that is enhanced by integrating ecological momentary intervention (EMI) texting. As such, this proposal will significantly build research capacity in South Africa to conduct telehealth tobacco treatment interventions using innovative EMI approaches enhancing participants' engagement, as well as state-of-the art evaluation approaches.

Registry
clinicaltrials.gov
Start Date
April 15, 2025
End Date
February 27, 2026
Last Updated
6 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult PLWHA CC smokers;
  • Speaks Afrikaans, or Xhosa, or English;
  • reports daily CC smoking (≥ 5 CPD);
  • Owns any type of mobile phone;
  • interested in reducing CC smoking but not necessarily trying to quit;
  • Receives HIV/AIDS care in one of the eight selected clinics follow-up rates.

Exclusion Criteria

  • are pregnant or breastfeeding;
  • unable to provide consent;
  • used tobacco products other than CC in the past 2 weeks (e.g., EC, cigarillo);
  • currently engaged in an attempt to quit CC smoking;
  • current major depressive or manic episode, current psychotic disorder, past-year suicide attempt, or current suicidal ideation with plan or intent. plan or intent.

Outcomes

Primary Outcomes

Follow-Up Rate at 6 Months

Time Frame: Month 6

Defined as the percent of participants who completed the 6-month follow-up.

Percent of Patients who Enroll in Counseling

Time Frame: Up to Month 6

Defined as the percentage of participants who start the intervention counseling sessions.

Recruitment Rate

Time Frame: Up to Month 6

Defined as the total number of participants recruited divided by the maximum number of recruiting sites, then divided by the total number of months that the trial recruited for.

Follow-Up Rate at 3 Months

Time Frame: Month 3

Defined as the percent of participants who completed the 3-month follow-up.

Client Satisfaction Questionnaire (CSQ-8) Score

Time Frame: Month 3

8-item assessment of satisfaction with the intervention. The total score is the sum of responses and ranges from 8 to 32, with higher numbers indicating greater satisfaction.

Secondary Outcomes

  • Percentage of Participants who Achieve 7-Day Point Prevalence Abstinence.(Month 3)
  • Change in American Thoracic Society Questionnaire Score(Baseline, Month 6)
  • Percentage of Participants who achieve 50% Reduction in Cigarettes Per Day (CPD), compared with Baseline(Up to Month 6)

Study Sites (1)

Loading locations...

Similar Trials